Payden & Rygel’s Merck & Co Inc Position
Does Payden & Rygel own Merck & Co Inc (MRK)? Yes — 198.1K shares worth $24M (+1.83% of its 13F portfolio) as of Q1 2026.
Position Value
$24M
Q1 2026
Shares
198.1K
% of Portfolio
+1.83%
Quarters Held
26
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 198.1K | $24M | +1.83% |
| Q4 2025 | 198.1K | $21M | +1.44% |
| Q3 2025 | 197.9K | $17M | +1.38% |
| Q2 2025 | 3.7K | $294,000 | +0.02% |
| Q1 2025 | 7.4K | $665,000 | +0.06% |
| Q4 2024 | 111.5K | $11M | +0.96% |
| Q3 2024 | 185.2K | $21M | +1.62% |
| Q4 2023 | 166.8K | $18M | +1.26% |
| Q2 2023 | 195.9K | $23M | +1.60% |
| Q1 2023 | 239.8K | $26M | +1.51% |
| Q4 2022 | 338.0K | $38M | +2.00% |
| Q3 2022 | 404.2K | $35M | +2.04% |
| Q2 2022 | 187.4K | $17M | +1.03% |
| Q1 2022 | 3.4K | $280,000 | +0.01% |
| Q4 2021 | 3.4K | $261,000 | +0.01% |
| Q3 2021 | 480.5K | $36M | +1.87% |
| Q2 2021 | 421.6K | $33M | +1.56% |
| Q1 2021 | 423.8K | $33M | +1.52% |
| Q4 2020 | 296.7K | $24M | +1.24% |
| Q3 2020 | 438.8K | $36M | +2.16% |
| Q2 2020 | 419.4K | $32M | +2.07% |
| Q1 2020 | 564.5K | $43M | +3.13% |
| Q4 2019 | 514.6K | $47M | +2.93% |
| Q3 2019 | 516.9K | $44M | +2.96% |
| Q2 2019 | 501.5K | $42M | +2.88% |
| Q1 2019 | 486.9K | $40M | +2.96% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Payden & Rygel’s full portfolio or all institutional holders of MRK.